In phase 2 clinical trials, this drug improved body weight, body fat, and glycated hemoglobin (HbA1c) levels in people with obesity, with or without T2D
While most people lose weight on Mounjaro, studies show about 5-10% of participants are non-responders who lose less than 5% body weight 3
Frequently asked questions Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates two hormonal pathways
Vitek serves as a consultant for Medtronic, Boston Scientific, and Abbott
Best overall vanilla protein shake Average mouthfeel score: 3.5/5 | Average texture/consistency score: 4.25/5 | Average flavor score: 3.63/5 | Overall average score: 3.79/5 The consistency of this Fairlife shake is what set it apart for testers
People who struggle with obesity or weight regain may experience several patterns: persistent hunger even after meals slow or stalled weight loss gradual regain of lost weight difficulty maintaining calorie restriction These patterns often reflect hormonal signals involved in appetite regulation
